Daehan New Pharm Co Ltd
KOSDAQ:054670
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Greggs PLC
LSE:GRG
|
UK |
|
J
|
Jiangxi Copper Co Ltd
XBER:JIX
|
CN |
|
DBAPPSecurity Co Ltd
SSE:688023
|
CN |
|
Organovo Holdings Inc
NASDAQ:ONVO
|
US |
|
Hangzhou Kelin Electric Co Ltd
SSE:688611
|
CN |
Daehan New Pharm Co Ltd
Research & Development
Daehan New Pharm Co Ltd
Research & Development Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Research & Development | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
D
|
Daehan New Pharm Co Ltd
KOSDAQ:054670
|
Research & Development
-₩6.9B
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-36%
|
CAGR 10-Years
-54%
|
|
|
Yuhan Corp
KRX:000100
|
Research & Development
-₩198.2B
|
CAGR 3-Years
-23%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-18%
|
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Research & Development
-₩169.7B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Research & Development
-₩195.8B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
2%
|
CAGR 10-Years
-2%
|
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Research & Development
-₩8.7B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
17%
|
CAGR 10-Years
-9%
|
|
|
C
|
Caregen Co Ltd
KOSDAQ:214370
|
Research & Development
-₩5.7B
|
CAGR 3-Years
3%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
Daehan New Pharm Co Ltd
Glance View
Daehan New Pharm Co., Ltd. engages in the production of pharmaceuticals and animal health goods. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-02-26. The firm provides two categories of products: human pharmaceutical products and animal pharmaceutical products. Its human pharmaceutical products include analgesics, anti-inflammatory drugs, antipyretics, antibacterial, antidiabetics, antihistamines, antineoplastics, immunosuppressants, cardiovascular drugs, gastrointestinal drugs, muscle relaxants, antispasmodics and others. Its animal pharmaceutical products include antibacterial, coccidiostats, antihelmintics, probiotic, nutrients, metabolic stimulants, disinfectants, functional supplement feeds, liver tonics, antihelmintics and others for poultries, cattle, sheep, swine and fishes.
See Also
What is Daehan New Pharm Co Ltd's Research & Development?
Research & Development
-6.9B
KRW
Based on the financial report for Sep 30, 2025, Daehan New Pharm Co Ltd's Research & Development amounts to -6.9B KRW.
What is Daehan New Pharm Co Ltd's Research & Development growth rate?
Research & Development CAGR 10Y
-54%
Over the last year, the Research & Development growth was -394%. The average annual Research & Development growth rates for Daehan New Pharm Co Ltd have been -44% over the past three years , -36% over the past five years , and -54% over the past ten years .
